LENA TIM: Open Payments
NPI 1407573736 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 36 payments from 18 companies in 2025. Trend: 2023 $1,354 · 2024 $1,753 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $136 |
| Merck Sharp & Dohme LLC | 5 | $91 |
| GlaxoSmithKline, LLC. | 3 | $85 |
| PFIZER INC. | 3 | $66 |
| Novo Nordisk Inc | 2 | $54 |
| Lilly USA, LLC | 3 | $51 |
| Amgen Inc. | 2 | $36 |
| ABBVIE INC. | 1 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Seqirus USA Inc | 1 | $26 |
Products named: REXULTI, Wegovy, SHINGRIX, EVENITY, VRAYLAR, TRELEGY ELLIPTA, MOUNJARO, GEMTESA.
Industry payments across CO — which companies pay providers there.
